Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Barclays iPath Series B SP 500 VIX ShortTerm Futures ETN VXX Geopolitical Risk Pricing Signals Equity Market Resilience Amid Iran Conflict DeEscalation Is Total SWZ stock rejecting resistance DTE Energy DTK Sector Impact Q4 2025 Earnings Beat Estimates White House Prediction Market Insider Trading Warning Regulatory Landscape Update Is Dragonfly DFLIW stock respecting key technical levels What guidance trend China SXT SXTC Bearish Momentum 20260429 BTSG BrightSpring reports Q4 2025 EPS below consensus estimates with shares dipping 037 in todays trading BCAT BlackRockCap management outlines capital allocation plans and sector outlook in its latest quarterly earnings call How ESS Tech GWH stacks up against the best in its class 175 20260508 Cibus CBUS Stock Analysis Climbs 117 Eyes on 135 20260519 Gulf GURE Q3 2023 Earnings EPS 017 In Line with Estimates Scotiabank Revises Wheaton Precious Metals Price Target Upward Sonoma Pharmaceuticals SNOA Q1 2026 Earnings Miss by Significant Key Takeaways NTB Stock Holds Steady Near Resistance Amid Modest Decline Private Payrolls Rise 109000 in April Exceeding Market Expectations ADP Report Shows Pantages PGAC Unchanged at 1053 RangeBound Trading 20260520 Cotality 65 of Homeowners Face Escrow Gaps as Property Taxes and Insurance Surge Protara Therapeutics TARA Q1 2026 Earnings Narrower Loss Beats Street Estimates on Cost Management ULH Q1 2026 Earnings A Significant Earnings Miss Amidst Operational Headwinds RRC Q1 2026 Earnings Strong EPS Beat Driven by Cost Discipline and Operational Efficiency FTRE Q1 2026 Earnings EPS Beats Estimates by Wide Margin Driving Positive Market Response QH Q4 2021 Earnings Massive EPS Miss Amidst Operational Challenges VOC Energy Trust Holds Steady at 313 Amid Flat Trading Session Clean Harbors CLH Holds Steady Near 287 Amid Narrow Trading Range Mayfair Gold MINE Faces Selling Pressure Testing Key Support at 262 CytomX Therapeutics CTMX Holds Steady Near Resistance After 325 Gain